Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanotechnology-based essential oil formulations for diabetic foot wound treatment
RBR-7gtxkptNot yet recruiting
- Sponsor
- CEPEC-HUUFMA
- Start
- Jan 2026
- Countries
- 1
01
Overview
Randomised, single-blind trial in diabetic foot ulcer (DFU) (2 arms), sponsored by CEPEC-HUUFMA. Primary endpoint: Wound healing index. Planned start Jan 2026; status: not yet recruiting.
02
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on RBR-7gtxkpt.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7gtxkpt.